ShEEP Request for Next Generation High Dimension Flow Cytometer

ShEEP 请求下一代高维流式细胞仪

基本信息

  • 批准号:
    9796482
  • 负责人:
  • 金额:
    --
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2019
  • 资助国家:
    美国
  • 起止时间:
    2019-01-01 至 2019-09-30
  • 项目状态:
    已结题

项目摘要

Inflammation and immunological mechanisms are at the epicenter of all disease mechanisms. High-parameter flow cytometry is a powerful analytical tool that will enable the Birmingham VA Medical Center (BVAMC) researchers to identify and analyze distinct phenotypes in the very heterogeneous populations of cells derived from various sources of animal models and human specimens. There is no high dimensional flow cytometer at the BVAMC or the affiliate, the University of Alabama at Birmingham (UAB), yet there is an acute need for BVAMC investigators to have access to such an instrument. The BD FACSymphony features an ultra-quiet VPX (also known as VITA 46), which is the next generation of ruggedized compact embedded electronic systems that supports up to 50 high-performance photomultiplier tubes (PMTs) and improves detection sensitivity to enable the user to identify and analyze rare cell subtypes in advance. In order to understand the causes of diseases such as cancer, kidney disease, heart failure, diabetes, or degenerative diseases of the nervous system, it is important to define the cell population not at just one point in time but at multiple times in a disease process. Multiparameter analysis improves the efficiency by requiring smaller sample volume and by increasing sample throughput. This is critical for human samples available at limited amounts from human tissue and body fluids. Increased number of parameters facilitates improved simultaneous functional characterization of cells by intracellular staining of phosphorylated targets, cytokine and growth factor production, analysis of cell cycle, apoptosis, mitochondria membrane polarization, etc. These capacities are critical for understanding a broad spectrum of single cells or fluids derived from VA patients in active studies by the BVAMC investigators. For example, in Dr. Mountz's work in Systemic Lupus Erythematosis (SLE), the BD FACSymphony will be used to specifically and very individually determine the pathogenic phenotype of autoreactive B cells and other cells in SLE patients and enable tailored precision medical therapy approaches. The important precision medicine approaches can be best utilized and targeted when the abnormal cell subpopulation in a specific individual and disease can be identified, and specifically suppressed. This is of considerable importance to facilitate the development of effective therapies for VA patients who have developed inflammatory and autoimmune diseases presented in this proposal. In another novel approach, Drs. Dell'Italia and Gaggar will utilize the BD Symphony to track the secretion of exosomes in acute and chronic lung and heart injury. Exosomes are membrane-bound structures secreted by a wide range of mammalian cell types carrying and transporting cellular cargo in normal and pathologic states. The ability to utilize flow cytometry to directly interrogate individual exosomes and their content is tremendously valuable and offers insight to the pathogenic features of a given exosome population. In each of the projects presented in this proposal, there is a similar targeted cellular approach for cardiac, pulmonary, vascular kidney disease and cancer, as well as immunological disease of the gastrointestinal tract and nervous system. The application of this exciting new technology will enhance funding capabilities and most importantly our research goals and mission of Veteran-centric medical care.
炎症和免疫机制是所有疾病机制的中心。高参数 流式细胞术是一种强大的分析工具,将使伯明翰退伍军人医疗中心 (BVAMC) 能够 研究人员识别和分析非常异质的细胞群体中的不同表型 来自各种来源的动物模型和人体标本。目前还没有高维流式细胞仪 BVAMC 或其附属机构阿拉巴马大学伯明翰分校 (UAB),但迫切需要 BVAMC 调查人员有权使用此类仪器。 BD FACSymphony 具有超静音功能 VPX(也称为 VITA 46),是下一代坚固耐用的紧凑型嵌入式电子产品 支持多达 50 个高性能光电倍增管 (PMT) 并改进检测的系统 灵敏度使用户能够提前识别和分析稀有细胞亚型。为了了解 癌症、肾病、心力衰竭、糖尿病或退行性疾病等疾病的原因 神经系统中,重要的是不仅要定义一个时间点上的细胞群,还要定义多个时间点上的细胞群。 一个疾病的过程。多参数分析通过需要更小的样品体积来提高效率 提高样品通量。这对于从人体中获取的数量有限的人体样本至关重要 组织和体液。参数数量的增加有利于改进同步功能 通过磷酸化靶标、细胞因子和生长因子的细胞内染色来表征细胞 生产、细胞周期分析、细胞凋亡、线粒体膜极化等。这些能力是 对于在积极的研究中了解来自 VA 患者的广泛单细胞或液体至关重要 BVAMC 调查员。例如,Mountz 博士在系统性红斑狼疮 (SLE) 方面的研究中,BD FACSymphony 将用于专门且非常单独地确定以下疾病的致病表型: SLE 患者体内的自身反应性 B 细胞和其他细胞,使定制的精准医疗方法成为可能。 当异常细胞出现异常时,重要的精准医疗方法可以得到最好的利用和靶向治疗。 可以识别特定个体和疾病的亚群,并进行针对性抑制。这是属于 促进针对患有 VA 患者的有效疗法的开发非常重要 患有本提案中提出的炎症和自身免疫性疾病。在另一种新颖的方法中, 博士。 Dell'Italia 和 Gaggar 将利用 BD Symphony 来追踪急性和慢性疾病中外泌体的分泌。 慢性肺和心脏损伤。外泌体是由多种细胞分泌的膜结合结构 在正常和病理状态下携带和运输细胞货物的哺乳动物细胞类型。有能力 利用流式细胞术直接询问单个外泌体,其内容非常有价值 提供对特定外泌体群体致病特征的深入了解。在提出的每个项目中 根据该提案,针对心脏、肺、血管肾疾病和其他疾病有类似的靶向细胞方法 癌症以及胃肠道和神经系统的免疫疾病。应用 这项令人兴奋的新技术将增强资助能力,最重要的是我们的研究目标和 以退伍军人为中心的医疗服务的使命。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Louis J. Dell'Italia其他文献

Gene expression and ultra-structural evidence for metabolic derangement in the primary mitral regurgitation heart
原发性二尖瓣反流心脏代谢紊乱的基因表达和超微结构证据
  • DOI:
    10.1093/ehjopen/oeae034
  • 发表时间:
    2024
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Mariame Selma Kane;J. X. M. Juncos;S. Manzoor;Maximiliano Grenett;Joo;Betty Pat;Mustafa I Ahmed;Clifton Lewis;James E Davies;Thomas S. Denney;Jonathan McConathy;Louis J. Dell'Italia
  • 通讯作者:
    Louis J. Dell'Italia
Nitric Oxide Synthase Modulates Genes Involved in Hepatic Steatosis, Hepatic Fibrosis and Inflammation
  • DOI:
    10.1016/j.freeradbiomed.2011.10.048
  • 发表时间:
    2011-11-01
  • 期刊:
  • 影响因子:
  • 作者:
    Michelle Smith Johnson;Balu Chacko;Junying Zheng;Louis J. Dell'Italia;Jianhua Zhang;Victor M. Darley-Usmar
  • 通讯作者:
    Victor M. Darley-Usmar
GW27-e0081 Angiotensin type II receptor protects cardiovascular functions at the onset of atherosclerosis in young apolipoprotein E-deficient mouse
  • DOI:
    10.1016/j.jacc.2016.07.663
  • 发表时间:
    2016-10-18
  • 期刊:
  • 影响因子:
  • 作者:
    Li Ming;Nawazish Naqvi;Eiji Yahiro;Eddie W. Bradley;Louis J. Dell'Italia;Ahsan Husain
  • 通讯作者:
    Ahsan Husain
Metabolic Dysfunction in Leukocytes Following Cardiac Surgery
  • DOI:
    10.1016/j.freeradbiomed.2012.10.457
  • 发表时间:
    2012-11-01
  • 期刊:
  • 影响因子:
  • 作者:
    Philip Kramer;Balu Chacko;Taegyu Choi;Michelle S. Johnson;Saranya Ravi;Louis J. Dell'Italia;Spencer J. Melby;James F. George;Victor M. Darley-Usmar
  • 通讯作者:
    Victor M. Darley-Usmar
The Effect of Renin-Angiotensin System Inhibition on All-Cause Mortality in Hospitalized Elderly Systolic Heart Failure Patients with Chronic Kidney Disease
  • DOI:
    10.1016/j.cardfail.2009.06.149
  • 发表时间:
    2009-08-01
  • 期刊:
  • 影响因子:
  • 作者:
    Ali Ahmed;Michael W. Rich;Richard M. Allman;Inmaculada Aban;Paul W. Sanders;Louis J. Dell'Italia;Donna K. Arnett;Thomas E. Love;George L. Bakris
  • 通讯作者:
    George L. Bakris

Louis J. Dell'Italia的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Louis J. Dell'Italia', 18)}}的其他基金

Allopurinol Improves Diastolic Function in African Americans with Resistant Hypertension
别嘌呤醇可改善患有难治性高血压的非裔美国人的舒张功能
  • 批准号:
    10701217
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Identifying Approaches to Enhance Bone and Cartilage Regeneration
确定增强骨和软骨再生的方法
  • 批准号:
    10629250
  • 财政年份:
    2017
  • 资助金额:
    --
  • 项目类别:
Pathophysiology of Extracellular Matrix and Desmin Breakdown in Volume Overload Heart
容量超负荷心脏中细胞外基质和结蛋白分解的病理生理学
  • 批准号:
    9236513
  • 财政年份:
    2017
  • 资助金额:
    --
  • 项目类别:
The Chymase Angiotensin-(1-12) Axis in Heart Disease
心脏病中的食糜酶血管紧张素 (1-12) 轴
  • 批准号:
    8811838
  • 财政年份:
    2014
  • 资助金额:
    --
  • 项目类别:
The Chymase Angiotensin-(1-12) Axis in Heart Disease
心脏病中的食糜酶血管紧张素 (1-12) 轴
  • 批准号:
    8967205
  • 财政年份:
    2014
  • 资助金额:
    --
  • 项目类别:
Xanthine Oxidase and Bioenergetic Function in Volume Overload
黄嘌呤氧化酶和容量超负荷时的生物能功能
  • 批准号:
    8457056
  • 财政年份:
    2010
  • 资助金额:
    --
  • 项目类别:
Xanthine Oxidase and Bioenergetic Function in Volume Overload
黄嘌呤氧化酶和容量超负荷时的生物能功能
  • 批准号:
    8059630
  • 财政年份:
    2010
  • 资助金额:
    --
  • 项目类别:
Xanthine Oxidase and Bioenergetic Function in Volume Overload
黄嘌呤氧化酶和容量超负荷时的生物能功能
  • 批准号:
    7898471
  • 财政年份:
    2010
  • 资助金额:
    --
  • 项目类别:
Xanthine Oxidase and Bioenergetic Function in Volume Overload
黄嘌呤氧化酶和容量超负荷时的生物能功能
  • 批准号:
    8235831
  • 财政年份:
    2010
  • 资助金额:
    --
  • 项目类别:
Chymase-Mediated MMP Activation in Ishemia Reperfusion Injury
缺血再灌注损伤中食糜酶介导的 MMP 激活
  • 批准号:
    8195546
  • 财政年份:
    2009
  • 资助金额:
    --
  • 项目类别:

相似海外基金

Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
  • 批准号:
    484000
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了